We analyzed whether presence of CI assessed by MoCA alters plasma levels of HMGB1, sRAGE, ROS/RNS, ApoD, and NRF2 in the AUD group, compared to those of the AD and control groups (Figure 2). This evidence concerns the gene HMGB1 and Alzheimer disease.